CEO Sten R. Sörensen will present the company with its revised clinical strategy for CS1 in rare disease PAH at BioStock Live on October 15, at 11.00 CET.
CEO Sten R. Sörensen will present the company with its revised clinical strategy for CS1 in rare disease PAH at BioStock Live on October 15, at 11.00 CET.